Effect of a Home-Based Wearable Continuous ECG Monitoring Patch on Detection on Undiagnosed Atrial Fibrillation
JAMA 320:146-155,139, Steinhubl, S.R.,et al, 2018
Cardiac Workup of Ischemic Stroke: Can We Improve Our Diagnostic Yield?
Stroke 40:2893-2898, Morris,J.G.,et al, 2009
The Canadian CT Head Rule for Patients with Minor Head Injury
Lancet 357:1391-1396, Stiell,I.G.,et al, 2001
Indications for Computed Tomography in Patients With Minor Head Injury
NEJM 343:100-105,138, Haydel,M.J. et al, 2000
Diagnosing Syncope
Ann Int Med 126:989-996, Linzer,M.,et al, 1997
Diagnosing Syncope, Part 2:Unexplained Syncope
Ann Int Med 127:76-86, Linzer,M.,et al, 1997
Diagnosing Stroke in Acute Dizziness and Vertigo
Stroke 49:788-795, Saber Tehrani, A.S.,et al, 2018
Cost-Effectiveness of Left Atrial Appendage Closure With the WATCHMAN Device Compared with Warfarin or Non-Vitamin K Antagonist Oral Anticoagulants for Secondary Prevention in Nonvalvular Atrial Fibrillation
Stroke 49:1464-1470, Reddy, V.Y.,et al, 2018
Cardiac Magnetic Resonance Imaging: A New Tool to Identify Cardioaortic Sources in Ischaemic Stroke
JNNP 88:31-37, Yaghi, S.,et al, 2017
Stroke as the Initial Manifestation of Atrial Fibrillation
Stroke 48:490-492, Lubitz, S.A.,et al, 2017
Oral Anticoagulants for Prevention of Stroke in Atrial Fibrillation: Systematic Review, Network Meta-Analysis, and Cost Effectiveness Analysis
BMJ 359:J5058, Lopez-Lopez, J.A.,et al, 2017
Cost-Effectiveness of Oral Anticoagulants for Ischemic Stroke Prophylaxis Among Nonvalvular Atrial Fibrillation Patients
Stroke 47:1555-1561, Shah, A.,et al, 2016
Potential Cost-Effectiveness of Ambulatory Cardiac Rhythm Monitoring After Cryptogenic Stroke
Stroke 47:2380-2385, Yong, J.H.E.,et al, 2016
Cost-Effectiveness of Apixaban, Dabigatran, Rivaroxaban, and Warfarin for Stroke Prevention in Atrial Fibrillation
Stroke 44:1676-1681, Harringotn, A.,et al, 2013
Cost-Effectiveness of Dabigatran Compared with Warfarin for Stroke Prevention in Patients with Atrial Fibrillation and Prior Stroke or Transient Ischemic Attack
Stroke 43:881-883, Kamel,H.,et al, 2012
Cost Efficiency of Anticoagulation With Warfarin to Prevent Stroke in Medicare Beneficiaries With Nonvalvular Atrial Fibrillation
Stroke 42:112-118, Mercaldi,C.J.,et al, 2011
Cost Effectiveness of Warfarin Versus Aspirin in Patients Older Than 75 Years With Atrial Fibrillation
Stroke 42:1717-1721, Jowett, S.,et al, 2011
Dabigatran Etexilate versus Warfarin in Management of Non-Valvular Atrial Fibrillation in UK Context: Quantitative Benefit-Harm and Economic Analyses
BMJ 343:d6333, Pink, J.,et al, 2011
Should TIA Patients Be Hospitalized or Referred to a Same-Day Clinic?
Neurol 77-2082-2088, Joshi, J.K.,et al, 2011
Optimal Screening Strategy for Familial Intracranial Aneurysms: A Cost-Effectiveness Analysis
Neurol 74:1671-1679, Bor,A.S.E., et al, 2010
Cost-Effectiveness of Outpatient Cardiac Monitoring to Detect Atrial Fibrillation After Ischemic Stroke
Stroke 41:1514-1520, Kamel,H., et al, 2010
Cost-Effectiveness of Multimodal CT for Evaluation Acute Stroke
Neurol 75:1678-1685, Young,K.C.,et al, 2010
Costs and Effectiveness of Ximelagatran for Stroke Prophylaxis in Chronic Atrial Fibrillation
JAMA 293:699-706, OBrien,C.L. &Gage,B.F., 2005
The New Antiepileptic Drugs, Clinical Applications
JAMA 291:615-620, LaRoche,S.M.&Helmers,S.L., 2004
In-Hospital Care Pathways for Stroke: A Cochrane Systematic Review
Stroke 34:587-588, Kwan,J. &Sandercock,P., 2003
The Canadian C-Spine Rule Versus the NEXUS Low-Risk Criteria in Patients with Trauma
NEJM 349:2510-2518, Stiell,I.G.,et al, 2003
Recommendations for the Management of Patients with Unruptured Intracranial Aneurysms
Stroke 31:2742-2750, Bederson,J.B.,et al, 2000
Diagnostic Testing for Coagulopathies in Patients With Ischemic Stroke
Stroke 31:3067-3078, Bushnell,C.D. & Goldstein,L.B., 2000
Should We Screen for Familial Intracranial Aneurysm?
Stroke 30:312-316, Crawley,F.,et al, 1999
Evaluation and Management of Intracranial Mass Lesions in AIDS
Rpt of Quality Stnds Subcomm of the AAN, Neurol 50:21-261998., , 1998
Cost-Effectiveness of Anticoagulation in Nonrheumatic A Fib in the Primary Prevention of Ischemic Stroke
Stroke 29:1827-1832, Lightowlers,S.&McGuire,A., 1998
Cost Effectiveness of Oral Compared with IV Antibiotic Therapy for Pts with Early Lyme Dis or Lyme Arthritis
NEJM 337:357-363, Eckman,M.H.,et al, 1997
Evaluation of Dementia:A Systematic Study of the Usefulness of the AAN Practice parameters
Neurol 49:925-935, Chui,H.&Zhang,Q., 1997
Echocardiographic Identif of Cardiovascular Sources of Emboli to Guide Clin Manag of Stroke:Cost-Effec Analysis
Ann Int Med 127:775-787, McNamara,R.L.,et al, 1997
Implementation of an Acute Stroke Program Decreases Hospitalization Costs and Length of Stay
Stroke 27:1040-1043, Wentworth,D.A.&Atkinson,R.P., 1996
Results of a Computerized Screening of Stroke Patients for Unjustified Hospital Stay
Stroke 27:639-644, Goldman,R.S.,et al, 1996
Evidence-Based Medicine, Critical Pathways, Practice Guidelines, & Managed Care:Prevention & Care of Stroke
Arch Neurol 53:867-871, Ringel,S.P.&Hughes,R.L., 1996
Routine Transesophageal Echocardiograhy for Cerebral Ischemia
Arch Int Med 156:1719-1723, Warner,M.F.&Kingson,I.M., 1996
Ten Steps in Characterizing and Diagnosing Patients with Peripheral Neuropathy
Neurol 47:10-17, Dyck,P.J.,et al, 1996
Management Protocol for an Enhancing Cerebral Lesion in HIV Infection
Conn Medicine 60:649-651, Finelli,P.F., 1996
A Simplified Six-Item Checklist for Screening for Fragile X Syndrome in the Pediatric Population
J Pediatr 129:611-614, Giangreco,C.A.,et al, 1996
Diagnosis and Evaluation of Dementia
Neurol 45:211-218, Corey-Bloom,J.,et al, 1995
Cost-Effectiveness of Warfarin and Aspirin for Prophylaxis of Stroke in Patients with Nonvalvular Atrial Fibrillation
JAMA 274:1839-1845, Gage,B.F.,et al, 1995
Stroke:The Way Things Really Are
Stroke 25:1290-1294, Scheinberg,P., 1994
Cost of Acute Stroke Care in Toronto, Canada
Stroke 25:1628-1631, Smurawska,L.T.,et al, 1994
Effect of a Stroke Protocol on Hospital Costs of Stroke Patients
Neurol 44:1961-1964, Bowen,J.&Yaste,C., 1994
Magnetic Resonance Imaging
NEJM 328:708-716, 785-7911993., Edelman,R.R.&Warach,S., 1993
A Model for Management of Patients with Stroke During the Acute Phase Outcome and Economic Implications
Stroke 24:1823-1827, Odderson,I.R.&McKenna,B.S., 1993
Cost Effectiveness of Primary Stroke Prevention in Atrial Fibrillation
BMJ 305:1457-1460, 14451992., Gustafsson,C.,et al, 1992